TAIM
NVO

TD Ameritrade Investment Management’s Novo Nordisk NVO Stock Holding History

TD Ameritrade Investment Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-3,906
Closed -$316K – 329
2023
Q2 		$316K Sell
3,906
-168
-4% -$13.7K ﹤0.01% 133
2023
Q1 		$324K Sell
4,074
-286
-7% -$20.3K ﹤0.01% 141
2022
Q4 		$295K Sell
4,360
-1,504
-26% -$88.2K ﹤0.01% 171
2022
Q3 		$292K Sell
5,864
-1,884
-24% -$101K ﹤0.01% 181
2022
Q2 		$432K Sell
7,748
-1,438
-16% -$79.8K ﹤0.01% 164
2022
Q1 		$510K Sell
9,186
-560
-6% -$28.7K ﹤0.01% 183
2021
Q4 		$546K Buy
9,746
+1,952
+25% +$106K ﹤0.01% 172
2021
Q3 		$271K Sell
7,794
-702
-8% -$33.9K ﹤0.01% 195
2021
Q2 		$356K Buy
8,496
+504
+6% +$19.5K ﹤0.01% 188
2021
Q1 		$279K Hold
7,992
– – ﹤0.01% 197
2020
Q4 		$279K Buy
7,992
+198
+3% +$6.84K ﹤0.01% 197
2020
Q3 		$271K Buy
7,794
+714
+10% +$23.8K ﹤0.01% 195
2020
Q2 		$232K Buy
7,080
+492
+7% +$15.7K ﹤0.01% 202
2020
Q1 		$198K Buy
6,588
+72
+1% +$2.14K ﹤0.01% 199
2019
Q4 		$189K Buy
6,516
+2,612
+67% +$72.3K ﹤0.01% 198
2019
Q3 		$101K Buy
3,904
+2,904
+290% +$73.4K ﹤0.01% 214
2019
Q2 		$26K Buy
1,000
+896
+862% +$22.1K ﹤0.01% 313
2019
Q1 		$3K Buy
104
+20
+24% +$492 ﹤0.01% 495
2018
Q4 		$2K Buy
84
+38
+83% +$844 ﹤0.01% 539
2018
Q3 		$1K Buy
+46
New +$1.12K ﹤0.01% 545

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

TD Ameritrade Investment Management's NVO Position: Q3 2023 in Review

TD Ameritrade Investment Management sold out of Novo Nordisk (NVO) in Q3 2023, closing a stake of 3,906 shares — an estimated $316K sold.

TD Ameritrade Investment Management first reported a position in NVO in Q3 2018 and held it in 20 quarters. The position peaked at $546K in Q4 2021. 1,308 funds tracked by Wall St. Rank hold NVO as of Q3 2023.

  • TD Ameritrade Investment Management reported no remaining Novo Nordisk position as of Q3 2023 after selling out during the quarter.
  • TD Ameritrade Investment Management sold 3,906 Novo Nordisk shares in Q3 2023, an estimated $316K.
  • TD Ameritrade Investment Management first reported a position in Novo Nordisk in Q3 2018 and held it in 20 quarters.
  • TD Ameritrade Investment Management's Novo Nordisk position peaked at $546K in Q4 2021.
  • 1,308 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2023.

Based on TD Ameritrade Investment Management's 13F filing for Q3 2023.